Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study

The purpose of this clinical study is to investigate the clinical feasibility and effectiveness of offline Positron-Emission-Tomography (PET) quality assurance for promoting the accuracy of proton and carbon ion beam therapy.

Saved in:
Bibliographic Details
Main Authors: Combs, Stephanie (Author) , Bauer, Julia (Author) , Unholtz, Daniel (Author) , Kurz, Christopher (Author) , Welzel, Thomas (Author) , Habermehl, Daniel (Author) , Haberer, Thomas (Author) , Debus, Jürgen (Author) , Parodi, Katia (Author)
Format: Article (Journal)
Language:English
Published: 03 April 2012
In: BMC cancer
Year: 2012, Volume: 12, Pages: 1-6
ISSN:1471-2407
DOI:10.1186/1471-2407-12-133
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-133
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-133
Get full text
Author Notes:Stephanie E. Combs, Julia Bauer, Daniel Unholtz, Christopher Kurz, Thomas Welzel, Daniel Habermehl, Thomas Haberer, Jürgen Debus and Katia Parodi
Description
Summary:The purpose of this clinical study is to investigate the clinical feasibility and effectiveness of offline Positron-Emission-Tomography (PET) quality assurance for promoting the accuracy of proton and carbon ion beam therapy.
Item Description:Gesehen am 29.08.2018
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-133